Page last updated: 2024-09-05

regadenoson and Death, Sudden, Cardiac

regadenoson has been researched along with Death, Sudden, Cardiac in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleich, S; El-Hajj, S; Ghimire, G; Hage, FG; Iskandrian, AE; Lester, D; Mckay, J	1
Borges-Neto, S; Dunning, A; Farzaneh-Far, A; O'Connor, CM; Oldan, JD; Shaw, LK	1
Ali, A; AlJaroudi, W; Campagnoli, T; Doukky, R; Fughhi, I; Wassouf, M	1
Ali, A; Campagnoli, T; Doukky, R; Fughhi, I; Wassouf, M	1

Trials

1 trial(s) available for regadenoson and Death, Sudden, Cardiac

Article	Year
Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:3 Topics: Causality; Comorbidity; Death, Sudden, Cardiac; Double-Blind Method; Exercise Test; Female; Heart Rate; Heart Rate Determination; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Risk Factors; Survival Rate; Tomography, Emission-Computed, Single-Photon; United States; Vasodilator Agents	2016

Article

Year

Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:3

Topics: Causality; Comorbidity; Death, Sudden, Cardiac; Double-Blind Method; Exercise Test; Female; Heart Rate; Heart Rate Determination; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Risk Factors; Survival Rate; Tomography, Emission-Computed, Single-Photon; United States; Vasodilator Agents

2016

Other Studies

3 other study(ies) available for regadenoson and Death, Sudden, Cardiac

Article	Year
The prognostic value of regadenoson myocardial perfusion imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:6 Topics: Adenosine A2 Receptor Agonists; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; United States	2015
Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:4 Topics: Adenosine; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; North Carolina; Prevalence; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Vasodilator Agents	2015
The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1 Topics: Age Distribution; Cardio-Renal Syndrome; Chicago; Comorbidity; Coronary Artery Disease; Death, Sudden, Cardiac; Exercise Test; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Purines; Pyrazoles; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Distribution; Single-Blind Method; Survival Rate; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2017